Skip to main content
SpringerLink
Log in

Optimizing Drug Development: Strategies to Assess Drug Metabolism/Transporter Interaction Potential—Toward a Consensus

  • Conference Report
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Molecular Pharmacology & Pharmacogenetics, Division of Clinical Sciences, University of Sheffield, The Royal Hallamshire Hospital, Sheffield, S10 2JF, United Kingdom

    Geoffrey T. Tucker

  2. School of Pharmacy & Pharmaceutical Sciences, University of Manchester, Manchester, M13 9PL, United Kingdom

    J. Brian Houston

  3. Office of Clinical Pharmacology & Biopharmaceutics (OCPB), Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland, 20852

    Shiew-Mei Huang

Authors
  1. Geoffrey T. Tucker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Brian Houston
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shiew-Mei Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tucker, G.T., Houston, J.B. & Huang, SM. Optimizing Drug Development: Strategies to Assess Drug Metabolism/Transporter Interaction Potential—Toward a Consensus. Pharm Res 18, 1071–1080 (2001). https://doi.org/10.1023/A:1010994022294

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1010994022294

Search

Navigation